These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 30215611)
61. Nanomedicines Lost in Translation. Guidolin K; Zheng G ACS Nano; 2019 Dec; 13(12):13620-13626. PubMed ID: 31800203 [TBL] [Abstract][Full Text] [Related]
62. Tumor Microenvironment on a Chip: The Progress and Future Perspective. Ahn J; Sei YJ; Jeon NL; Kim Y Bioengineering (Basel); 2017 Jul; 4(3):. PubMed ID: 28952543 [TBL] [Abstract][Full Text] [Related]
63. Modeling of brain tumors using Raju R R; AlSawaftah NM; Husseini GA Heliyon; 2024 May; 10(10):e31402. PubMed ID: 38807869 [TBL] [Abstract][Full Text] [Related]
65. Acoustofluidic black holes for multifunctional in-droplet particle manipulation. Liu P; Tian Z; Yang K; Naquin TD; Hao N; Huang H; Chen J; Ma Q; Bachman H; Zhang P; Xu X; Hu J; Huang TJ Sci Adv; 2022 Apr; 8(13):eabm2592. PubMed ID: 35363512 [TBL] [Abstract][Full Text] [Related]
66. Multifunctional biomolecule nanostructures for cancer therapy. Wang J; Li Y; Nie G Nat Rev Mater; 2021; 6(9):766-783. PubMed ID: 34026278 [TBL] [Abstract][Full Text] [Related]
68. Ex vivo isolated human vessel perfusion system for the design and assessment of nanomedicines targeted to the endothelium. Lysyy T; Bracaglia LG; Qin L; Albert C; Pober JS; Tellides G; Saltzman WM; Tietjen GT Bioeng Transl Med; 2020 May; 5(2):e10154. PubMed ID: 32440561 [TBL] [Abstract][Full Text] [Related]
69. Protein and Proteome Measurements with Microfluidic Chips. Lazar IM; Gulakowski NS; Lazar AC Anal Chem; 2020 Jan; 92(1):169-182. PubMed ID: 31665883 [No Abstract] [Full Text] [Related]
70. Evaluating Nanoparticles in Preclinical Research Using Microfluidic Systems. Zhu D; Long Q; Xu Y; Xing J Micromachines (Basel); 2019 Jun; 10(6):. PubMed ID: 31234335 [TBL] [Abstract][Full Text] [Related]
71. Microfluidic Devices: A Tool for Nanoparticle Synthesis and Performance Evaluation. Gimondi S; Ferreira H; Reis RL; Neves NM ACS Nano; 2023 Aug; 17(15):14205-14228. PubMed ID: 37498731 [TBL] [Abstract][Full Text] [Related]
72. Microfluidic-Based Platform for the Evaluation of Nanomaterial-Mediated Drug Delivery: From High-Throughput Screening to Dynamic Monitoring. Yang Y; Liu S; Geng J Curr Pharm Des; 2019; 25(27):2953-2968. PubMed ID: 31362686 [TBL] [Abstract][Full Text] [Related]
73. Evaluating nanomedicine with microfluidics. He Z; Ranganathan N; Li P Nanotechnology; 2018 Dec; 29(49):492001. PubMed ID: 30215611 [TBL] [Abstract][Full Text] [Related]
74. Organ-on-a-chip platforms for accelerating the evaluation of nanomedicine. Chen X; Zhang YS; Zhang X; Liu C Bioact Mater; 2021 Apr; 6(4):1012-1027. PubMed ID: 33102943 [TBL] [Abstract][Full Text] [Related]
75. Tumor-on-a-chip model for advancement of anti-cancer nano drug delivery system. Tian C; Zheng S; Liu X; Kamei KI J Nanobiotechnology; 2022 Jul; 20(1):338. PubMed ID: 35858898 [TBL] [Abstract][Full Text] [Related]
76. Organ-on-a-Chip: A Preclinical Microfluidic Platform for the Progress of Nanomedicine. Rodrigues RO; Sousa PC; Gaspar J; Bañobre-López M; Lima R; Minas G Small; 2020 Dec; 16(51):e2003517. PubMed ID: 33236819 [TBL] [Abstract][Full Text] [Related]